展覽10.29

非贖回協議和經濟利益轉讓

此非贖回協議和經濟權益轉讓(以下簡稱“協議”)由BurTech Acquisition corp.（下稱“公司”）、BurTech LP LLC（下稱“贊助商”）和簽署的投資者（統稱爲“投資者”).

前言

鑑於，贊助方目前持有公司b類普通股的股份，這些股份最初是在公司首次公開發行（"IPO"）之前由贊助方通過定向增發購買的創始股份”);

而，該公司已計劃 2023 年 3 月 10 日的股東特別會議（此類預定會議，包括任何正式批准的續會） ”會議”）的目的是尋求股東批准該修正案等 公司的第二份經修訂和重述的公司註冊證書（”憲章”) 將日期延長至 公司必須完成初步的業務合併（”初始業務合併”) 九個人 再過幾個月，直到 2023 年 12 月 15 日（此類擬議的《憲章》修正案，將在會議上進行審議和表決） 會議，”延期修正案”);

鑑於根據公司章程規定，公司股東可以贖回其每股面值爲0.0001美元的A類普通股，最初作爲公司首次公開發行中單位的一部分出售（無論是在我們的首次公開發行中購買的還是後來在開放市場上購買的）（“公開股份”以及創始人股份一起，同“普通股”在延期修正案中，根據章程規定的條款進行操作要行使您的贖回權，您必須確保您的銀行或經紀人遵守此處識別的要求，包括向轉讓代理提交書面請求，要求轉讓您的股份以獲得現金，並在2023年[•]，美國東部時間5:00 p.m.（特別會議安排的投票日前兩個工作日）之前將您的股份交付給轉讓代理。只有在您持有股份並在選舉日之前持續持有股份的情況下，您才有資格在股份贖回時獲得現金。”);

鑑於根據本協議的條款和條件，贊助方希望轉讓給投資者，而投資者希望從贊助方獲得，附表A中列明的創始人股份數量（“指定證券”），以便在公司完成首次業務組合時轉讓給投資者，並且在向投資者轉讓指定證券之前，贊助方希望將指定證券的經濟利益分配給投資者。

因此現在鑑於本協議中載明的相互約定和協議以及爲了充分的、有價值的考慮，特此承認收到並認爲足夠，投資者、發起人和公司在此達成以下協議：

1.       轉讓條款.

1.1 (a) 根據本協議的條款和條件，贊助商同意，如果（a）在會議當天紐約時間下午5點，投資者持有投資者股份（如下所定義），（b）投資者在會議中未行使與該投資者股份相關的贖回權，以及（c）會議批准並生效延期修正案，並由公司向特拉華州州務卿提交修憲，那麼贊助商在下述條件符合後同意（i）將附表A中列明的指定證券在下面1.2節所述條件滿足時，轉讓給投資者，不另行給予對應的證券；以及（ii）將附表A中列明的指定證券的經濟權益（如下所定義）轉讓給投資者。

交付投資者 股份「股份」應指（i）[ ]公開發行股份中的較小者；以及（ii）代表將在持續有效地行使本次會議紅股權後公開發行股份總數9.9% 的股份，包括那些與其他公司股東簽訂類似於本協議的不可贖回協議且日期環繞會議日期左右簽訂的公開發行股份；但是，如果投資者股份數量少於497,113，則指定證券數量將相應減少。

(c) 贊助商同意最遲於紐約時間上午9:00於會議日期的第一個工作日之前，向投資者提供信息，說明(i)根據換股權力行使而選定要贖回的公開股票數量，(ii)在公司實施此類贖回後剩餘的公開股票數量，以及（iii）爲本協議的投資者股份目的而構成的確定公開股票數量的計算結果，在會議日期後開倉前

1.2 贊助商和投資者特此同意，被轉讓證券的轉讓須符合以下條件： (i) 初次業務組合完成；以及 (ii) 投資者（或其允許的受讓人之一（如《信函協議》所述））與公司、贊助商、公司的官員和董事以及簽署了相關部分的公司其他股東執行一份《信函協議》的加入協議，日期爲2021年12月10日現在，該文件存在截至日期，《信函協議》最上述，第1.8節中描述。被許可的受讓人”))執行一份加入協議，日期爲2021年12月10日，由公司、贊助商、公司的官員和董事以及公司其他簽署方成爲簽署人，如本條款第1.8節所述。信函協議”），由公司、贊助商、公司的官員和董事以及公司其他簽署方成爲簽署人，如本條款第1.8節所述。

在滿足上述條件後，贊助商將立即將指定證券分配並轉讓給投資者（或其被許可的受讓人）。贊助商保證並同意根據上述情況促進該轉讓給投資者（或其被許可的受讓人）。

1.3.        調整股份數量。如果任何時候，創始人股份的總數因公司普通股進行合併、組合、細分或重新分類或其他類似事件（除了根據公司章程將創始人股轉換爲A類普通股的情況）而增加或減少，則自上述合併、組合、細分、重新分類或類似事件的生效日期起，本協議中提及的所有股票數量按照普通股的增減比例進行調整。

1.4.        兼併 或者重組等如果發生任何涉及公司的重組、再資本化、重新分類、合併或合併的情況，其中其普通股轉換成或兌換爲證券、現金或其他財產，那麼，在任何此類重組、再資本化、重新分類、合併或合併之後，贊助商應將與公司普通股相對應的各創始人股份在其收到後，在此轉讓的每份分配證券轉換或兌換爲的證券種類和金額、現金或其他財產。

1.5.        沒收、轉讓等投資者不需要放棄或轉讓已指定證券或在此項下與指定證券相關的任何權利。 投資者承認，根據贊助方的修正和重訂有限責任公司協議（就目前日期而言，稱爲「贊助方有限責任公司協議」），在初始業務組合之前或在進行初次業務組合時，贊助方的管理成員（「經理人」）有權促使贊助方使創始人股份受到應得的、沒收、轉讓或其他限制，或修改發行創始人股份的條件或在確立相同股份的文件中規定的任何限制或其他條款（包括贊成任何此類修正），或與創始人股份有關的任何其他安排，並且經理人被授權實施這些應得的、沒收、轉讓、限制、修正或安排，包括與應得的、沒收、轉讓、限制、修正或安排有關的針對減少或提前解除限制的安排，根據他們自行和絕對裁量決定的原因和金額。 贊助方承認並同意，任何此類應得的、沒收、轉讓、限制、修正或安排僅適用於除了指定證券以外的創始人股份，指定證券和經濟權益的條款和條件不會因任何此類應得的、沒收、轉讓、限制、修正或安排而發生變化。

1.6.        股份交付；其他文件轉讓指定證券時，贊助商應通過公司的過戶代理通過電子記賬股票的轉讓向投資者交付指定證券。本協議各方同意簽署、確認和交付進一步的文件，並進行所有必要或適當的其他行爲，以執行本協議的目的和意圖。

1.7.        註冊權的分配 與本協議項下將指定證券轉讓給投資者同時，贊助方在此將其在指定證券方面與投資者有關的所有權利、職責和義務轉讓給投資者，根據某份於2021年12月10日簽署的《備案權協議》（按照協議簽署日的情況，簡稱“註冊權協議”），由公司、贊助方以及簽署該協議的公司其他股東所簽署，特此向投資者聲明並確認，一旦投資者收到指定證券，（i）投資者將成爲《備案權協議》下的「持有人」，（ii）指定證券將成爲該《備案權協議》下的「備案證券」。贊助方應根據《備案權協議》向公司提交此類轉讓的書面通知。投資者應向公司提供一份書面協議，根據《備案權協議》同意遵守《備案權協議》的條款和約定，作爲該《備案權協議》下的「持有人」，就指定證券（在收購後）作爲「備案證券」受其約束。

1.8.       加入信函協議在將劃撥的證券轉讓給投資者的過程中，投資者應當執行一份加入信函協議，其實質形式如附件b所示（“加入協議”），根據該協議，投資者應當同意與公司僅僅受限於信函協議第7條，僅涉及劃撥證券，並且按照《註冊權協議》中的條款和規定作爲該協議下的「持有人」（在收購後）</s>，「註冊證券」。</s>。

1.9.        終止本協議及簽署人的各項義務應在以下情況之一提前終止：(a) 公司股東未批准延期修正案的會議、或公司決定不繼續執行延期修正案；(b) 各方的所有義務履行完畢；(c) 公司清算或解散；(d) 各方之間的書面協議；(e) 如果投資者在會議中行使其贖回權，並且該行使在會議開展前未被撤銷。儘管本協議中的任何規定相反，贊助商轉讓指定證券給投資者的義務應以以下條件爲前提：(i) 滿足第1.2節中規定的條件；(ii) 投資者未在會議中行使其對應於這些投資者股份數目的贖回權。

2.           經濟利益轉讓。

2.1.        在滿足1.1節中規定的條件後，保薦方特此將其在《附件A》中列明的轉讓證券數量的經濟權利、所有權和利益轉讓給投資者，受1.3節規定的調整。這份經濟利益代表着保薦方根據保薦方有限責任公司協議獲得的分紅派息和其他分配權利，分配給《附件A》中列明的轉讓證券數量，由保薦方直接持有創始股票。經濟權益」，受1.3節規定的調整。經濟權益代表贊助方有權接收由贊助方有限責任公司協議按照《附件A》中列明的轉讓證券數量分配的分紅派息和其他分配。這些轉讓證券由贊助方直接持有的創始股份所代表。

投資者承認並同意，它不是贊助方的成員，因已被指定的證券或經濟利益，對贊助方事項進行投票的權利，或者對任何指定證券進行投票的權利，也不具備在根據本協議轉讓任何此類股份給投資者之前投票指定證券的權利。

2.3.        投資者確認並同意，如果根據其經濟權益有權收取任何以普通股或其他非現金財產支付的分紅派息或其他分配，而該股份受到第7條信函協議規定的轉讓限制和/或封鎖期限的約束，贊助商應當在根據第1條向該投資者轉讓指定證券的同時，轉讓其在該等分紅或分配中的所有權利、所有權和利益。

2.4.        如果在首次業務組合完成之時，關於第1節中指定證券的轉讓條件未能滿足任何指定證券的經濟利益，則投資者應在該時自動將其在該指定證券中的經濟利益無償轉讓回贊助商。

3.           投資者的陳述和保證。投資者代表並保證，並同意贊助者：

3.1.        政府無推薦或批准投資者知道，沒有聯邦或州政府機構對轉讓證券的發行做出過任何評審或推薦。

3.2.       合格投資者投資者屬於「認定投資者」，如《1933年證券法》修訂的501(a)規定下定義的那樣，並且承認此處考慮的出售是在依賴於《證券法》下對「認定投資者」提供的定向增發豁免以及州法下類似豁免的情況下進行的。

3.3.        目的投資者僅出於投資目的獲取指定證券，爲其自己的帳戶（和/或允許的成員或關聯公司帳戶或利益），而非違反證券法分發指定證券，並且投資者目前沒有安排出售指定證券以及通過任何個人或實體進行，除非根據本協議或信件協議和/或註冊權協議的規定。

3.4.        轉讓限制、信託帳戶和贖回權利。

投資者確認並同意，在根據本文轉讓前，受讓證券已經，並在任何轉讓給投資者後可能繼續受到轉讓限制以及信函協議第7段規定的其他限制。

投資者理解並同意，指定的證券不享有，並放棄對公司首次公開發行（「IPO」）所募集款項存入的信託帳戶中的任何款項的任何權利、利益或要求。 信託帳戶或者因爲信託帳戶清算而分配的任何款項。

投資者放棄在延期修正案中選擇讓公司贖回任何投資者股份的權利，同意不在延期修正案中贖回或以其他方式行使任何贖回投資者股份的權利，並同意撤銷並撤銷先前作出的任何關於在延期修正案中贖回投資者股份的選舉。毋庸置疑，本協議的任何內容均不旨在限制或禁止投資者酌情行使的權利，即(i) 贖回任何公開發行股份（不包括與延期修正案相關的投資者股份）或(ii) 出售或以其他方式處置任何公開發行股份（但不包括股東大會前的投資者股份）。

投資者承認並理解，指定證券是在不涉及《證券法》規定的美國公開發行交易中提供的，並且未在《證券法》註冊。如果將來投資者決定提供、轉售、質押或以其他方式轉讓指定證券，則只能（A）根據根據《證券法》的有效註冊聲明、（B）根據《證券法》制定的144號規定下的免註冊規定（如果可行），或者（C）根據《證券法》的任何其他可用豁免規定提供、轉售、質押或以其他方式轉讓，並且在任何情況下都要遵守任何州或其他管轄區的適用證券法。投資者同意，如果擬轉讓指定證券或其中任何權益（除按照《證券法》的有效註冊聲明或144號規定進行以外），作爲任何此類轉讓的前提條件，投資者可能需要向公司提供符合公司要求的律師意見，證明無需就擬轉讓的指定證券進行註冊。在無註冊或其他可用豁免註冊的情況下，投資者同意不會轉讓指定證券。

3.5.        投票投資者同意，將導致其受控聯營公司投票（或導致被投票）或簽署並交付一份書面同意書（或導致簽署並交付一份書面同意書）所有所擁有的普通股，在適用記錄日期時，由任何一方在股東大會上支持延期修正案，並導致所有這些股份被視爲出席股東大會以建立法定人數。

3.6.       資深投資者投資者在金融事務方面有經驗，並且能夠評估在指定證券投資中的風險和收益。

3.7.        損失風險投資者知道，對已指定證券的投資具有高度投機性，並面臨重大風險。投資者高知特並理解與收購已指定證券相關的風險，包括本協議、贊助方有限責任公司協議和有關可轉讓性的轉讓信函中描述或規定的限制。投資者有能力承擔對已指定證券的投資的經濟風險，並能夠在無限期內承受對此類投資的全部損失。

3.8.       獨立調查。投資者已經獨立調查了公司，並且沒有依賴任何第三方提供的信息或陳述，也沒有依賴贊助方或贊助方的代表或代理人口頭或書面的明示或默示陳述或保證，除非在本協議中另有規定。投資者熟悉公司的業務、運營和財務狀況，並且已經有機會向公司管理層提出問題並得到答覆，詢問有關賦予證券的擬議出售以及有關公司和約定條款的情況，並已經獲得所請求的有關公司的其他信息的全部權限。投資者確認已提供其請求的所有文件，並已向其提供了有關此投資的所有其他信息，且其已請求了這些信息。

3.9.       組織和授權如果一個實體投資者是依法組織並存在於其設立的法域下，並且具有獲取指定證券、簽訂本協議並履行投資者在此項下須履行的一切義務的全部必要權力和權威。

3.10.      非美國投資者如果投資者不是根據1986年修訂的美國國內稅收法案第7701（a）（30）節及其以下頒佈的法規（統稱「法典」）所定義的美國人，投資者特此聲明，它已經確信其在與任何邀請訂閱指定證券或使用本協議有關的情況下，已經滿足了其司法管轄區的法律的全部遵守，包括（i）其司法管轄區對指定證券的收購的法律要求，（ii）適用於該收購的任何匯率限制，（iii）可能需要獲得的任何政府或其他同意，以及（iv）對該收購、持有、贖回、出售或轉讓指定證券的與收購相關的收入稅及其他稅後果，如果有的話。投資者的認購、付款以及持續持有指定證券的受益所有權不會違反投資者司法管轄區的任何適用證券或其他法律。

3.11.      授權本協議已由投資者合法授權、執行和交付，並且（假設經贊助商和公司的合法授權、執行和交付）是投資者的有效和約束性協議，根據其條款對投資者具有強制執行力，除非適用破產、清算、欺詐性轉讓、停止支付、重組或類似法律有限制或一般影響債權人權利和救濟的執行的，或由普遍適用的公平原則以及賠償和貢獻權利的執行可能受到聯邦和州證券法律或公共政策原則的限制。

3.12.      沒有衝突。根據本協議的執行、交付和履行以及投資者完成此處交易，不違反、不衝突或不構成違約：(i) 投資者的組織文件，(ii) 投資者是一方的任何協議或文書，或(iii) 適用於投資者的任何法律、法規、規章，或對投資者適用的任何命令、判決或法令，在第(ii)和第(iii)項中，若可能預計可能會阻止投資者履行本協議項下義務。

3.13.      贊助方未提供任何建議投資者已有機會通過其自己的法律顧問和投資稅務顧問審查本協議及本協議約定的交易以及與投資者的函件協議。除本協議明確由贊助方作出的任何聲明或陳述外，投資者僅僅依賴於這些顧問，並不仰賴贊助方或其任何代表或經紀作出的任何明示或默示的聲明或陳述，無論出於何種原因，包括但不限於法律、稅務或投資建議，涉及本投資、贊助方、公司、指定證券、本協議約定的交易或任何司法管轄區的證券法。

3.14.      依賴陳述與擔保投資者理解已指定證券是根據《證券法》的登記要求豁免條款以及各州法律法規的類似規定向投資者提供和出售的，贊助商依賴投資者在本協議中所載陳述、擔保、協議、確認和理解的真實性和準確性，以確定該等規定的適用性。

3.15.      沒有一般宣傳。在第4.5節，假設贊助商在保證準確性的情況下，投資者購買的指定證券不是因爲或隨後於根據《證券法》Regulation D下的一般招攬或廣告，包括但不限於在任何報紙、雜誌或類似媒體上發表的廣告、文章、通知或其他溝通，或通過電視或無線電廣播或任何研討會或會議，其與一般招攬或廣告有關的參會人員。

3.16.      經紀人未向投資者支付任何中介費或佣金，也沒有人可以在與被轉讓證券的收購有關的交易中獲得或有權獲得報酬或佣金，投資者也無權獲得或接受任何此類費用或佣金。

4.           贊助商的陳述和擔保。贊助商向投資者聲明並保證，並同意：

4.1.        權力和權威贊助商是一家有限責任公司，根據德拉華州法律成立併合法存在，並且作爲有限責任公司具有一切必要的有限責任公司權力和權限，可以簽訂本協議，並履行贊助商在本協議下需要履行的所有義務，包括轉讓、出售和轉讓指定證券。

4.2.        授權所有板塊贊助商及其官員、董事和成員必要的公司行動已經被採取，用以授權、簽署和交付本協議以及履行贊助商根據本協議規定的所有義務。本協議已經由贊助商正式簽署和交付（假設投資者已經經過合法授權、簽署和交付），構成贊助商的合法、有效和具有約束力的義務，根據其條款可對贊助商進行強制執行，除非適用於破產、清償不足、欺詐轉讓、暫停清償、重組或類似法律，涉及或一般影響債權人權利和救濟強制執行的法律，或根據一般應用的公平原則，以及對賠償和分攤權利的執行可能會受到聯邦和州證券法或公共政策原則的限制。

4.3.        所有板塊的證券贊助商是指派證券的記錄和實際所有者，並擁有良好和有市場銷售價值的指派證券的所有權，且在將指派證券轉讓給投資者之前，將作爲指派證券的記錄和實際所有者，所有權將不受任何形式的留置權、抵押、擔保權益、索賠、擔保、協議、期權、表決信託、代理投票和其他任何形式的安排或限制（除了適用於創始人股份普遍及適用證券法的轉讓限制和其他條款）。買方根據本文提供的，將作爲指派證券轉讓給投資者的指派證券，在轉讓時將不受任何形式的留置權、抵押、擔保權益、索賠、擔保、協議、期權、表決信託、代理投票和其他任何形式的安排或限制的限制（除了適用於創始人股份普遍情況、信函協議和適用的證券法）。指派證券經過妥善授權，已完全支付，並且是無需再次徵稅的。

4.4.        No Conflicts. The execution, delivery and performance of this Agreement and the consummation by the Sponsor of the transactions contemplated hereby do not violate, conflict with or constitute a default under (i) the certificate of formation or the Sponsor LLC Agreement, (ii) any agreement or instrument to which the Sponsor is a party or by which it is bound (including the Letter Agreement and the Sponsor LLC Agreement) or (iii) any law, statute, rule or regulation to which the Sponsor is subject or any order, judgment or decree to which the Sponsor is subject. The Sponsor is not required under federal, state or local law, rule or regulation to obtain any consent, authorization or order of, or make any filing or registration with, any court or governmental agency or self-regulatory entity in order for it to perform any of its obligations under this Agreement or transfer the Assigned Securities in accordance with the terms hereof.

4.5.        No General Solicitation. The Sponsor has not offered the Assigned Securities by means of any general solicitation or general advertising within the meaning of Regulation D of the Securities Act, including but not limited to any advertisement, article, notice or other communication published in any newspaper, magazine, or similar media or broadcast over television or radio or any seminar or meeting whose attendees have been invited by any general solicitation or general advertising.

4.6.        Brokers. No broker, finder or intermediary has been paid or is entitled to a fee or commission from or by the Sponsor in connection with the sale of the Assigned Securities nor is the Sponsor entitled to or will accept any such fee or commission.

4.7.        Transfer Restrictions. Until termination of this Agreement, the Sponsor shall not transfer any of the Assigned Securities or any economic benefit of the Assigned Securities other than any transfer pursuant to the Sponsor LLC Agreement in connection with an Initial Business Combination.

4.8.        Reliance on Representations and Warranties. The Sponsor understands and acknowledges that Investor is relying upon the truth and accuracy of the representations, warranties, agreements, acknowledgments and understandings of the Sponsor set forth in this Agreement.

5.           Trust Account.

5.1         Until the earlier of (a) the consummation of the Company’s Initial Business Combination; (b) the liquidation of the Trust Account; and (c) 24 months from consummation of the Company’s initial public offering or such later time as the stockholders of the Company may approve in accordance with the Charter, the Company will maintain the investment of funds held in the Trust Account in interest-bearing United States government securities within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended, having a maturity of 185 days or less, or in money market funds meeting the conditions of paragraphs (d)(1), (d)(2), (d)(3) and (d)(4) of Rule 2a-7 promulgated under the Investment Company Act of 1940, as amended, which invest only in direct U.S. government treasury obligations, or maintain such funds in cash in an interest-bearing demand deposit account at a bank. The Company further confirms that, in order to mitigate the current uncertainty surrounding the implementation of the Inflation Reduction Act of 2022, funds held in the Trust Account, including any interest thereon, will not be used to pay for any excise tax liabilities with respect to any future redemptions prior to or in connection with the Extension Amendment, an Initial Business Combination or liquidation of the Company.

5.2        Trust Account Waiver. Investor acknowledges that the Company established the Trust Account containing the proceeds of the Company’s IPO (including interest accrued from time to time thereon) for the benefit of its public shareholders and certain other parties (including the underwriters of the IPO). For good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Investor hereby agrees (on its own behalf and on behalf of its related parties) that it does not now and shall not at any time hereafter have any right, title, interest or claim of any kind in or to any assets held in the Trust Account, and it shall not make any claim against the Trust Account, arising as a result of, in connection with or relating in any way to this Agreement (any and all such claims are collectively referred to hereafter as the “Released Claims”); provided, that, for the sake of clarity, the Released Claims shall not include any rights or claims of the Shareholder or any of its related parties as a shareholder of the Company to the extent related to or arising from any shares of the Company.

6.           Governing Law; Jurisdiction; Waiver of Jury Trial. This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of New York, without giving effect to its principles or rules of conflict of laws to the extent such principles or rules would require or permit the application of the laws of another jurisdiction. The parties hereto hereby waive any right to a jury trial in connection with any litigation pursuant to this Agreement and the transactions contemplated hereby. With respect to any suit, action or proceeding relating to the transactions contemplated hereby, the undersigned irrevocably submit to the jurisdiction of the United States District Court or, if such court does not have jurisdiction, the New York state courts located in the Borough of Manhattan, State of New York, which submission shall be exclusive.

7.           Assignment; Entire Agreement; Amendment.

7.1.        Assignment. Any assignment of this Agreement or any right, remedy, obligation or liability arising hereunder by either the Sponsor or Investor shall require the prior written consent of the other party; provided, that no such consent shall be required for any such assignment to one or more affiliates of the assigning party.

7.2.        Entire Agreement. This Agreement sets forth the entire agreement and understanding between the parties as to the subject matter thereof and merges and supersedes all prior discussions, agreements and understandings of any and every nature among them.

7.3.       Amendment. Except as expressly provided in this Agreement, neither this Agreement nor any term hereof may be amended, waived, discharged or terminated other than by a written instrument signed by the party against whom enforcement of any such amendment, waiver, discharge or termination is sought.

7.4.       Binding upon Successors. This Agreement shall be binding upon and inure to the benefit of the parties hereto and to their respective heirs, legal representatives, successors and permitted assigns.

8.          Notices. Unless otherwise provided herein, any notice or other communication to a party hereunder shall be sufficiently given if in writing and personally delivered or sent by facsimile or other electronic transmission with copy sent in another manner herein provided or sent by courier (which for all purposes of this Agreement shall include Federal Express or another recognized overnight courier) or mailed to said party by certified mail, return receipt requested, at its address provided for herein or such other address as either may designate for itself in such notice to the other. Communications shall be deemed to have been received when delivered personally, on the scheduled arrival date when sent by next day or 2nd-day courier service, or if sent by facsimile upon receipt of confirmation of transmittal or, if sent by mail, then three days after deposit in the mail. If given by electronic transmission, such notice shall be deemed to be delivered (a) if by electronic mail, when directed to an electronic mail address at which the party has provided to receive notice; and (b) if by any other form of electronic transmission, when directed to such party.

9.           Counterparts. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party, it being understood that both parties need not sign the same counterpart. Counterparts may be delivered via facsimile, electronic mail (including any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic Signatures and Records Act or other applicable law, e.g., www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.

10.         Survival; Severability

10.1.     Survival. The representations, warranties, covenants and agreements of the parties hereto shall survive the closing of the transactions contemplated hereby.

10.2.      Severability. In the event that any provision of this Agreement becomes or is declared by a court of competent jurisdiction to be illegal, unenforceable or void, this Agreement shall continue in full force and effect without said provision; provided that no such severability shall be effective if it materially changes the economic benefit of this Agreement to any party.

11.         Headings. The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in construing or interpreting this Agreement.

12.         Disclosure; Waiver. As soon as practicable, but in no event later than one business day, after execution of this Agreement, the Company will file a Current Report on Form 8-K under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (the “Form 8-K”), disclosing, to the extent not previously disclosed, (a) the material terms of this Agreement and (b) any other material non-public information that the Sponsor, the Company, or any person acting on behalf of either has provided to Investor at any time prior to the filing of the Form 8-K. The parties to this Agreement shall cooperate with one another to assure that such disclosure is accurate. The Company agrees that the name of the investor shall not be included in any public disclosures related to this Agreement unless required by applicable law, regulation or stock exchange rule. Investor (i) acknowledges that the Sponsor may possess or have access to material non-public information which has not been communicated to the Investor; (ii) hereby waives any and all claims, whether at law, in equity or otherwise, that he, she, or it may now have or may hereafter acquire, whether presently known or unknown, against the Sponsor or any of the Company’s officers, directors, employees, agents, affiliates, subsidiaries, successors or assigns relating to any failure to disclose any non-public information in connection with the transaction contemplated by this Agreement, including any potential business combination involving the Company, including without limitation, any claims arising under Rule 10-b(5) of the Exchange Act; and (iii) is aware that the Sponsor is relying on the truth of the representations set forth in Section 3 of this Agreement and the foregoing acknowledgement and waiver in this Section 12, in connection with the transactions contemplated by this Agreement. The Sponsor and the Company acknowledge and represent that upon the filing of the Form 8-K, Investor shall not be in possession of any material non-public information received from the Sponsor, the Company, or any person acting on behalf of either.

13.        Independent Nature of Rights and Obligations. Nothing contained herein, and no action taken by any party pursuant hereto, shall be deemed to constitute Investor and the Sponsor as, and the Sponsor acknowledges that Investor and the Sponsor do not so constitute, a partnership, an association, a joint venture or any other kind of entity, or create a presumption that Investor and the Sponsor are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated by this Agreement or any matters, and the Sponsor acknowledges that Investor and the Sponsor are not acting in concert or as a group, and the Sponsor shall not assert any such claim, with respect to such obligations or the transactions contemplated by this Agreement.

14.         Most Favored Nation. In the event the Sponsor has entered or enters into one or more other non-redemption agreements before or after the execution of this Agreement in connection with the Meeting (each, an “Other Agreement” and, the Company stockholder party thereto, an “Other Investor”), the Sponsor represents and covenants that the terms of such Other Agreement are not or will not be materially more favorable to such Other Investor than the terms of this Agreement are in respect of Investor. In the event that any Other Investor is afforded any materially more favorable terms than Investor, the Sponsor shall promptly inform Investor of such more favorable terms in writing, and Investor shall have the right to elect to have such more favorable terms included herein, in which case the parties hereto shall promptly amend this Agreement to effect the same.

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the date first above written.

[Signature Page to Non-Redemption Agreement]

[Signature Page to Non-Redemption Agreement]

Exhibit A

EXHIBIT B

FORM OF JOINDER TO LETTER AGREEMENT AND REGISTRATION RIGHTS AGREEMENT

[            ], 2023

Reference is made to that certain Non-Redemption Agreement and Assignment of Economic Interest, dated as of March [ ], 2023 (the “Agreement”), by and among [ ], as representative of the Investors listed on Schedule A attached hereto (“Investor”), BurTech Acquisition Corp. (the “Company”) and BurTech LP LLC (the “Sponsor”), pursuant to which Investor shall be entitled to acquire securities of the Company from the Sponsor. Capitalized terms used and not otherwise defined herein shall have the meanings given to such terms in the Agreement.

By executing this joinder, Investor hereby agrees, as of the date first set forth above, that Investor (i) shall become a party to that certain Letter Agreement, dated December 10, 2021 (as it exists on the date of the Agreement, the “Letter Agreement”), by and among the Company, the Sponsor, officers and directors of the Company, and the other stockholders of the Company signatory thereto, solely with respect to Section 7 of the Letter Agreement, and shall be bound by, and shall be subject to the restrictions set forth under, the terms and provisions of such section of the Letter Agreement as an Insider (as defined therein) solely with respect to its Assigned Securities; and (ii) shall become a party to that certain Registration Rights Agreement, dated December 10, 2021 (as it exists on the date of the Agreement, the “Registration Rights Agreement”), by and among the Company, the Sponsor, and the other stockholders of the Company signatory thereto, and shall be bound by the terms and provisions of the Registration Rights Agreement as an Investor (as defined therein) and entitled to the rights of an Investor under the Registration Rights Agreement and the Assigned Securities (together with any other equity security of the Company issued or issuable with respect to any such Assigned Securities by way of a share dividend or share subdivision or in connection with a combination of shares, recapitalization, merger, consolidation or reorganization) shall be “Registrable Securities” thereunder.

For the purposes of clarity, it is expressly understood and agreed that each provision contained herein, in the Letter Agreement (to the extent applicable to Investor) and the Registration Rights Agreement is between the Company and Investor, solely, and not between and among Investor and the other stockholders of the Company signatory thereto.

This joinder may be executed in two or more counterparts, and by facsimile, all of which shall be deemed an original and all of which together shall constitute one instrument.

[ ]